Section of Cardiac Surgery, Yale School of Medicine, New Haven, Connecticut.
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut.
Ann Thorac Surg. 2018 Oct;106(4):1095-1104. doi: 10.1016/j.athoracsur.2018.05.081. Epub 2018 Jul 2.
Using the national Society of Thoracic Surgeons Adult Cardiac Surgery Database data for thoracic aortic surgical procedures for aortic aneurysm, this study aimed to (1) characterize patients' risk profiles and outcomes, (2) evaluate center volume-outcome relationships across US centers, and (3) identify risk factors for operative mortality.
Between 2011 and 2016, 53,559 operations for ascending aortic aneurysm performed across 1,045 centers in the United States were identified. Logistic regression related baseline characteristics and comorbidities to operative mortality. Ten-fold cross-validation was performed to estimate sensitivity and specificity across a range of the discrimination threshold. Centers were stratified into five strata by average annual case volume. Predicted probability of operative mortality was calculated from the model and was used to evaluate patients' risk profiles across the volume strata.
Operative mortality occurred in 3.2% of all cases and in 2.2% of elective cases. Only 24 (2.3%) centers performed ≥50 cases annually, whereas 609 (58.3%) centers performed fewer than five cases annually. Multiple logistic regression, of which the c-index was 0.80, revealed that compared with centers with ≥50 cases, centers with fewer than five cases had an increased risk of mortality (odds ratio, 2.50; 95% confidence interval, 2.08 to 3.01; p < 0.0001). The predicted probability of operative mortality was similar across the volume strata, but the observed mortality rate varied significantly, with lower volume yielding higher operative mortality.
Proximal thoracic aortic surgical procedures for aortic aneurysms in the United States are associated with a low operative mortality rate of 2.2% for elective cases. Risk of operative death decreases significantly at an annual center volume of more than 20 to 25 cases per year.
本研究利用美国胸外科医师学会成人心脏外科学会数据库中胸主动脉手术治疗主动脉瘤的数据,旨在:(1)描述患者的风险概况和结局;(2)评估美国各中心的中心容量-结局关系;(3)确定手术死亡率的危险因素。
在 2011 年至 2016 年间,在美国 1045 个中心共进行了 53559 例升主动脉瘤手术。使用逻辑回归分析了基线特征和合并症与手术死亡率的关系。对 10 倍交叉验证进行了敏感性和特异性的估计,范围跨越了一系列的判别阈值。根据平均每年的病例数将中心分为五个层次。从模型中计算手术死亡率的预测概率,并用于评估不同容量层次的患者风险概况。
所有病例中有 3.2%发生了手术死亡率,择期病例中有 2.2%发生了手术死亡率。只有 24 个(2.3%)中心每年的手术量≥50 例,而 609 个(58.3%)中心每年的手术量少于 5 例。多变量逻辑回归的 C 指数为 0.80,显示与手术量≥50 例的中心相比,手术量少于 5 例的中心死亡风险增加(比值比,2.50;95%置信区间,2.08 至 3.01;p<0.0001)。预测手术死亡率在各容量层次上相似,但观察到的死亡率差异显著,低容量中心的手术死亡率更高。
美国胸主动脉手术治疗主动脉瘤的手术死亡率较低,择期手术的死亡率为 2.2%。手术死亡率在每年中心手术量超过 20 至 25 例时显著降低。